Sep 25 |
OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
|
Sep 18 |
Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
|
Aug 13 |
Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
Aug 10 |
Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
|
Jul 2 |
Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
|
May 10 |
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
|
May 10 |
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
|
May 10 |
Q1 2024 Lineage Cell Therapeutics Inc Earnings Call
|
May 6 |
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
|